Clinical impact of push enteroscopy in patients with gastrointestinal bleeding of unknown origin

Bezet, Alexis; Cuillerier, Emmanuel; Landi, Bruno; Marteau, Philippe; Cellier, Christophe

doi:10.1016/s1542-3565(04)00397-0

Cited by 17 publications

(7 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…45 Overt bleeding has been found to be predictive for positive findings at push enteroscopy, which can change management in 40% to 75% of patients in this setting. [46][47][48][49][50][51] Studies evaluating long-term outcomes of patients undergoing push enteroscopy have shown conflicting results. One study indicated that recurrent rebleeding occurs in 33% of patients, with a trend toward frequent rebleeding in patients with angioectasias.…”

Section: Push Enteroscopymentioning

confidence: 99%

Enteroscopy

Chauhan¹,

Manfredi²,

Dayyeh³

et al. 2015

Gastrointestinal Endoscopy

View full text Add to dashboard Cite

Noninvasive imaging with CT and magnetic resonance enterography or direct visualization with wireless capsule endoscopy can provide valuable diagnostic information and direct therapy. Enteroscopy technology and techniques have evolved significantly and allow diagnosis and therapy deep within the small bowel, previously attainable only with intraoperative enteroscopy. Push enteroscopy, readily available in most endoscopy units, plays an important role in the evaluation and management of lesions located up to the proximal jejunum. Currently available device-assisted enteroscopy systems, DBE, SBE, and spiral enteroscopy each have their technical nuances, clinical advantages, and limitations. Newer, on-demand enteroscopy systems appear promising, but further studies are needed. Despite slight differences in parameters such as procedural times, depths of insertion, and rates of complete enteroscopy, the overall clinical outcomes with all overtube-assisted systems appear to be similar. Endoscopists should therefore master the enteroscopy technology based on institutional availability and their level of technical expertise.

show abstract

Section: Push Enteroscopymentioning

confidence: 99%

Enteroscopy

Chauhan¹,

Manfredi²,

Dayyeh³

et al. 2015

Gastrointestinal Endoscopy

View full text Add to dashboard Cite

show abstract

“…In one study of 105 patients with OGIB with a mean follow up of 29 mo, resolution of bleeding occurred in 69% of patients [90] . PE impacts upon clinical management in 40%-50% of patients with OGIB [74,91] . Decreased transfusion requirements and improvement in functional status one year post treatment have been found with PE [92] .…”

Section: Push Enteroscopymentioning

confidence: 99%

Evaluation and outcomes of patients with obscure gastrointestinal bleeding

Santhakumar

Liu

2014

WJGP

View full text Add to dashboard Cite

Core tip: This article examines the role of current diagnostic modalities for the investigation of obscure gastrointestinal bleeding (OGIB) and outcomes in patients undergoing these investigations. Capsule endoscopy and double balloon enteroscopy remain the cornerstone of diagnostic and therapeutic management. The diagnostic and therapeutic capabilities of certain modalities are influenced by the nature of bleeding in OGIB. Longterm outcome data in patients with OGIB is limited but is most promising for capsule endoscopy.Santhakumar C, Liu K. Evaluation and outcomes of patients with obscure gastrointestinal bleeding. World J Gastrointest Pathophysiol 2014; 5(4

show abstract

“…5,7,[20][21][22] This has important implications for referral indication. 7 In 9% of patients, lesions found were within the reach of a standard gastroscope, hence lowering the true yield of PE.…”

Section: Discussionmentioning

confidence: 99%